Concepedia

Hannah M. Knochelmann

HM

Statistics

Publications

11

Citations

432

H-Index

10

Active since

2019

Affiliations

Medical University of South Carolina(Current)

Emory University

MUSC Hollings Cancer Center

The Ohio State University

Piedmont Cancer Institute

Hannah M. Knochelmann is an author at Medical University of South Carolina specializing in cancer immunotherapy, oncology, and immunotherapy.

ORCID

Publications per year

2019–2025

11

Publications

11

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Hannah M. Knochelmann, Joshua D. Horton, Sixue Liu et al. · Cell Reports Medicine · 2021 · 97 citations · Full text

, , +17

Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 <sup>+</sup> T cells

Connor J. Dwyer, Dimitrios C. Arhontoulis, Guillermo O. Rangel Rivera et al. · European Journal of Immunology · 2020 · 66 citations · Full text

, , +17

Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma

Sixue Liu, Hannah M. Knochelmann, Shirley H. Lomeli et al. · Cell Reports Medicine · 2021 · 57 citations · Full text

, , +13

Identification of human CD4 <sup>+</sup> T cell populations with distinct antitumor activity

Michelle H. Nelson, Hannah M. Knochelmann, Stefanie R. Bailey et al. · Science Advances · 2020 · 51 citations · Full text

, , +3

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner

Michael B. Ware, Maggie Phillips, Christopher McQuinn et al. · JCI Insight · 2023 · 37 citations · Full text

, , +17

1–5 of 11